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The Question: How do direct to consumer
advertisements inﬂuence prescription patterns
for reproductive health products?
●
●
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History
Regulation today
What regulation looks like in the world
Behavioral outcomes of ads
Arguments for and against
Human impact
An example
Even with all of that this will fall short of comprehensive

First, a little history
● 1960

First oral contraceptive
approved by FDA
● 1983

● 1965

Oral contraceptives made
available to married women

-

● 1972

FDA memorandum
deﬁnies parameters of
pharmaceutical
advertisements
● 1997 -

● 1969

-

The pill is made legal
for unmarried women
to use

FDA alteres requirements for
television ads to require "adequate
provision" for risk information
● 2005

Congress and the FDA
develop ﬁrst set of drug
advertisement guidelines
● 1970 Formula and safety
information for the pill
changed
● 1996 Claritin runs commercial
without any risk
information

-

Pharmaceutical Research and
Manufacturers of America released its own
updated regulations for advertising
Siegel, 2012
Ventola, 2011

Where is Regulation Today?
●

●

The FDA creates and enforces regulation
○ It has limited funding
○ This promotes industry self regulation (Almashat et al., 2016)
Regulation has loopholes
○ Ads don’t have to list full safety information
○ Digital drug ads use scrolling to hide the risk information
○ All ads can refer viewers to a website for more information (Ventola,
2011)

Regulation and Design
●

●

Advertisements are built on six appeals
○ Ego, social, sensory, routine, acute need, and rational.
○ Ration and ego are used in pharmaceutical ads (Tsai & Lancaster, 2012).
Most prescription drugs also have websites.
○ Small screens and site design hide unwanted information
○ Accessible parts use the same appeals as ads (Ledford, 2009).
■ Sites are functionally more advertisements

How Advertising Guides Behavior
●

●

●

Increasing product awareness through ads increases interest in a product
○ In the case of the HPV vaccine, patients not already vaccinated who saw
ads showed more intent to get vaccinated than those who had not seen
the ads but were aware of the vaccine (Manika, Ball & Stout, 2014).
Advertisements can also incite communication with peers
○ Increases the likelihood women will discuss a prescription with their
doctor (Young, Lipowski & Cline, 2005).
Physicians reports also show advertisement inﬂuence on patient requests
(Parker & Pettijohn, 2003).

The Human Impact
Direct to consumer ads increase prescription interactions in several ways.
●

●

When DTC ads are the best or only education people have access to, their
education is biased.
○ This can lead people to request drugs that are not right for them.
Doctors receive their information from pharmaceutical companies as well
(Parker & Pettijohn, 2003).

An illustrated example: Nuvaring

Digital ad

Print ad
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